Filters
Use basic filters below or open advanced options for more precise results.
Last dataset refresh: 22 Jun 2026
| Product name | Classification | Strength | Form | Manufacturer | Country of origin | Status | Registered On | Action | |
|---|---|---|---|---|---|---|---|---|---|
|
SERTLE 50
|
Conventional Medicines | 50mg / Tablet | Tablet | BIOVENTURE HEALTHCARE FZE, United Arab Emirates, Dubai | United Arab Emirates | Active | 18 Aug 2022 | View details → | |
|
SERTLE 50
|
Conventional Medicines | 50mg / Tablet | Tablet | BIOVENTURE HEALTHCARE FZE, United Arab Emirates, Dubai | United Arab Emirates | Active | 18 Aug 2022 | View details → | |
|
Setofilm® 4mg
|
Conventional Medicines | 4 mg/Film | Film | LTS Lohmann Therapie-Systeme AG, Germany, 56626 Andernach | United Kingdom | Active | 18 May 2022 | View details → | |
|
Setofilm® 8mg
|
Conventional Medicines | 8 mg/Film | Film | LTS Lohmann Therapie-Systeme AG, Germany, 56626 Andernach | United Kingdom | Active | 18 May 2022 | View details → | |
|
SEVADEEN 1% Mouthwash/ Gargle
|
GSL Products | 1% | Solution | Fine Health Care Fzc, United Arab Emirates, Ajman | United Arab Emirates | Active | 07 Feb 2023 | View details → | |
|
SEVADEEN THROAT SPRAY
|
GSL Products | 0.45% | Spray | Fine Health Care Fzc, United Arab Emirates, Ajman | United Arab Emirates | Active | 29 Mar 2023 | View details → | |
|
SEVADEEN THROAT SPRAY
|
GSL Products | 0.45% | Spray | Fine Health Care Fzc, United Arab Emirates, Ajman | United Arab Emirates | Active | 29 Mar 2023 | View details → | |
|
SEVELARED 800mg
|
Conventional Medicines | 800 mg/Tablet | Tablet | Dr.Reddy's Laboratories Limited FTO-SEZ Process Unit-01, India, Srikakulam | United States of America | Active | 15 Jan 2025 | View details → | |
|
SEVELARED 800mg
|
Conventional Medicines | 800 mg/Tablet | Tablet | Dr.Reddy's Laboratories Limited FTO-SEZ Process Unit-01, India, Srikakulam | United States of America | Active | 15 Jan 2025 | View details → | |
|
SEVEN OCEANS
|
GSL Products | Combination | Capsule | SOFTGEL HEALTHCARE PRIVATE LIMITED, India, Kancheepuram District | India | Active | 01 Oct 2015 | View details → | |
|
SEVEN SEAS MAXEPA™ FORTE
|
GSL Products | combination | Capsule | Catalent Italy S.P.A., Italy, Aprilia (LT) | United Kingdom | Active | 14 Oct 2021 | View details → | |
|
SEVEN SEAS® JOINTCare™ MAX
|
GSL Products | combination | Capsule & Tablet | THOMPSON & CAPPER LIMITED, United Kingdom, Runcorn, Cheshire, WA7 1PH | United Kingdom | Active | 11 Aug 2021 | View details → | |
|
seventy hyal 2000
|
Medical Devices for Humans | 1.5 % (30mg / 2 mL) | Injection | SAVIO INDUSTRIAL S.r.l, Italy, 16019 RONCO SCRIVIA (GENOVA) | Italy | Active | 14 Jul 2025 | View details → | |
|
SEVIKAR HCT® 20 mg/5 mg/12.5 mg
|
Conventional Medicines | 20 mg / 5 mg /12.5 mg | Tablet | SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO. LTD., Saudi Arabia, Jeddah | Saudi Arabia | Active | 01 May 2019 | View details → | |
|
SEVIKAR HCT® 40 mg/10 mg/12.5 mg
|
Conventional Medicines | 40 mg/10 mg/12.5 mg /Tablet | Tablet | SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO. LTD., Saudi Arabia, Jeddah | Saudi Arabia | Active | 01 May 2019 | View details → | |
|
SEVIKAR HCT® 40 mg/10 mg/25 mg
|
Conventional Medicines | 40 mg/10 mg/25 mg /Tablet | Tablet | SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO. LTD., Saudi Arabia, Jeddah | Saudi Arabia | Active | 01 May 2019 | View details → | |
|
SEVIKAR HCT® 40 mg/5 mg/25 mg
|
Conventional Medicines | 40 mg/5 mg/25 mg / Tablet | Tablet | SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO. LTD., Saudi Arabia, Jeddah | Saudi Arabia | Active | 01 May 2019 | View details → | |
|
SEVIKAR HCT® 40mg/5 mg/12.5 mg
|
Conventional Medicines | 40 mg/5 mg/12.5 mg / Tablet | Tablet | SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO. LTD., Saudi Arabia, Jeddah | Saudi Arabia | Active | 01 May 2019 | View details → | |
|
SEVIKAR® 20/10 mg
|
Conventional Medicines | 20/10 mg/tablet | Tablet | SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO. LTD., Saudi Arabia, Jeddah | Saudi Arabia | Active | 29 Nov 2015 | View details → | |
|
SEVIKAR® 20/5 mg
|
Conventional Medicines | 20/5 mg/tablet | Tablet | SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO. LTD., Saudi Arabia, Jeddah | Saudi Arabia | Active | 29 Nov 2015 | View details → | |
|
SEVIKAR® 40/10 mg
|
Conventional Medicines | 40/10 mg/tablet | Tablet | SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO. LTD., Saudi Arabia, Jeddah | Saudi Arabia | Active | 29 Nov 2015 | View details → | |
|
SEVIKAR® 40/5 mg
|
Conventional Medicines | 40/5 mg/tablet | Tablet | SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO. LTD., Saudi Arabia, Jeddah | Saudi Arabia | Active | 29 Nov 2015 | View details → | |
|
SEVOFLURANE USP (BAXTER)
|
Conventional Medicines | 250ml/Bottle | Inhalation Gas | BAXTER HEALTH CARE CORPORATION, United States of America, Puerto Rico | United States of America | Active | 24 Mar 2025 | View details → | |
|
Sevoflurane USP (Shanghai Hengrui Pharmaceuticals)
|
Conventional Medicines | 100% | Solution | Shanghai Hengrui Pharmaceutical Co., Ltd., China, Shanghai | China | Active | 31 Aug 2020 | View details → |
Compare selected products
0 of 3 selected